Foghorn Therapeutics (FHTX)
(Delayed Data from NSDQ)
$5.99 USD
-0.12 (-1.96%)
Updated May 3, 2024 04:00 PM ET
After-Market: $6.02 +0.03 (0.50%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $-0.55 | 0.00% |
Earnings Summary
For their last quarter, Foghorn Therapeutics (FHTX) reported earnings of -$0.57 per share, beating the Zacks Consensus Estimate of $-0.79 per share. This reflects a positive earnings surprise of 27.85%. Look out for FHTX's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.55 per share, reflecting a year-over-year increase of 24.66%.
Earnings History
Price & Consensus
Zacks News for FHTX
Foghorn Therapeutics Inc. (FHTX) Upgraded to Buy: Here's What You Should Know
FHTX: What are Zacks experts saying now?
Zacks Private Portfolio Services